News and Media

Latest News Release
01/31/2024

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Durablue™ Sterilization Wrap Receives FDA Clearance for Use with Ethylene Oxide Sterilizers
06/18/2012
Latest Clearance Means DuraBlue™ Sterilization Wrap is Cleared for Use With More Sterilization Modalities Than Any Other Wrap in U.S. Market

DUBLIN, Ohio, June 18, 2012Cardinal Health today announced Food and Drug Administration (FDA) clearance (K120542) for use of its DuraBlue™ Sterilization Wrap with Ethylene Oxide sterilizers. With this latest clearance, DuraBlue™ Sterilization Wrap is FDA cleared for use with the most sterilization modalities of any sterilization wrap in the U.S. market.

“This clearance is an affirmation of our commitment to creating solutions for our customers’ diverse needs, to continuous contributions that can help improve the efficiency of the health care system, and to regulatory compliance,” said Greg Groenke, General Manager of Environmental Technologies at Cardinal Health.”

Cardinal Health DuraBlue™ Sterilization Wrap previously received FDA clearances for use with the following sterilization modalities:

  • Pre-Vacuum Steam Sterilization at 270 degrees Fahrenheit for four minutes (K112211)
  • Johnson and Johnson STERRAD® 100S (K112283)
  • Lumen, Non-Lumen and Flexible Cycles in the Amsco® V-PRO® 1, Amsco® V-PRO® 1 Plus, and Amsco® V-PRO® maX Low Temperature Sterilization Systems (K112918)

Sterilization wrap is critical for the productive use of reusable surgical instruments, as it enables the effective sterilization of medical devices contained in instrument trays and maintains their sterility The new Cardinal Health DuraBlue Sterilization Wrap can help bring efficiencies to the sterilization process while maintaining a high standard of aseptic technique. Its double-layer construction enables users to save time by using the simultaneous wrapping technique, eliminating the need for double wrapping with single-layer wrap.

DuraBlue Sterilization Wrap is made with non-woven, polypropylene SMS technology for strength, durability and microbial protection. DuraBlue Sterilization Wrap is available in six color-coded basis weight models, providing durable protection for everything from lightweight linen packs to heavy instrument trays weighing up to 25 pounds. The wrap also is available in 14 sizes ranging from 12 inches by 12 inches to 54 inches by 90 inches.

To learn more about the new Cardinal Health DuraBlue Sterilization Wrap product, contact Nick Soler, Category Manager of Sterile Packaging, at 1-847-887-6403 or nick.soler@cardinalhealth.com

About Cardinal Health

Headquartered in Dublin, Ohio, Cardinal Health, Inc. (NYSE: CAH) is a $103 billion health care services company that improves the cost-effectiveness of health care.As the business behind health care, Cardinal Health helps pharmacies, hospitals, ambulatory surgery centers and physician offices focus on patient care while  reducing costs, enhancing efficiency and improving quality. Cardinal Health is an essential link in the health care supply chain, providing pharmaceuticals and medical products to more than 60,000 locations each day. The company is also a leading manufacturer of medical and surgical products, including gloves, surgical apparel and fluid management products. In addition, the company supports the growing diagnostic industry by supplying medical products to clinical laboratories and operating the nation's largest network of radiopharmacies that dispense products to aid in the early diagnosis and treatment of disease. Ranked #21 on the Fortune 500, Cardinal Health employs more than 30,000 people worldwide. More information about the company may be found at cardinalhealth.com and @CardinalHealth on Twitter.

 

More Company News
04/02/2024

The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

03/26/2024

Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will...

03/15/2024

Cardinal Health (NYSE: CAH) today announced that the company has received approval by the Science Based Targets initiative (SBTi) for its near-term science-based greenhouse gas (GHG) emissions...

02/29/2024

Study reveals impact of dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability DUBLIN, Ohio, Feb. 29, 2024...

View all company news »